Jia et al. proved that fisetin-treated human pancreatic cancer PANC-1 cells show increased autophagy, which is mediated by p8 through the p53/PKC-α pathway, and combination with autophagy inhibitors can significantly strengthen the effect of fisetin (52). The gene discussed is TP53; the disease is pancreatic neoplasm.